Across TCGA pan-cancer cohorts, RNA5SP292 RNA is linked to patient survival in 4 of 34 cancer types, making it the most broadly survival-associated RNA5SP292 data layer.

The strongest signal is observed in glioblastoma multiforme (GBM), where higher RNA5SP292 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RNA5SP292 expression acts as an unfavorable survival marker, although some lineages such as KIRC show a favorable association.

GBM, HNSC, and LGG are the cancer types where RNA5SP292 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
GBM	OS	Tertile	All	0.020	0.416	<.001	36	view →
HNSC	OS	Tertile	IV	0.119	0.711	<.001	36	view →
LGG	OS	Tertile	All	0.325	0.834	<.001	27	view →
KIRC	DFS	Tertile	All	1.000	0.616	.046	6	view →

Pink = unfavorable, green = favorable. Showing the 4 strongest of 4 lineages.

Exploration

Same gene, other analysis: RNA5SP292 tumor-vs-normal RNA expression · all RNA5SP292 data types